Effects of Anesthesia and Anesthetic Techniques on Metastasis of Lung Cancers: A Narrative Review

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19(11):1450–1464. doi:10.1038/nm.3391
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271. doi:10.3322/caac.21235
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385. doi:10.3322/caac.21565
   PubMed Web of Science ®Google Scholar
• Park Y, Kitahara T, Takagi R, Kato R. Does surgery for breast cancer induce angiogenesis and thus promote metastasis? Oncology. 2011;81(3–4):199–205. doi:10.1159/000333455
   PubMed Web of Science ®Google Scholar
• Harting MT, Blakely ML. Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg. 2006;15(1):25–29. doi:10.1053/j.sempedsurg.2005.11.005
   PubMedGoogle Scholar
• Leong SP, Cady B, Jablons DM, et al. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006;25(2):221–232. doi:10.1007/s10555-006-8502-8
   PubMed Web of Science ®Google Scholar
• Inada T, Kubo K, Kambara T, Shingu K. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can J Anaesthes. 2009;56(3):222–229. doi:10.1007/s12630-008-9035-0
   PubMed Web of Science ®Google Scholar
• Woo JH, Baik HJ, Kim CH, et al. Effect of propofol and desflurane on immune cell populations in breast cancer patients: a randomized trial. J Korean Med Sci. 2015;30(10):1503–1508. doi:10.3346/jkms.2015.30.10.1503
   PubMed Web of Science ®Google Scholar
• Loop T, Dovi-Akue D, Frick M, et al. Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology. 2005;102(6):1147–1157. doi:10.1097/00000542-200506000-00014
   PubMed Web of Science ®Google Scholar
• Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–1339. doi:10.1213/01.ANE.0000082995.44040.07
   PubMed Web of Science ®Google Scholar
• Lukoseviciene V, Tikuisis R, Dulskas A, Miliauskas P, Ostapenko V. Surgery for triple-negative breast cancer- does the type of anaesthesia have an influence on oxidative stress, inflammation, molecular regulators, and outcomes of disease? J BUON. 2018;23(2):290–295.
   PubMed Web of Science ®Google Scholar
• Wall T, Sherwin A, Ma D, Buggy DJ. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth. 2019;123(2):135–150. doi:10.1016/j.bja.2019.04.062
   PubMed Web of Science ®Google Scholar
• Wang J, Cheng CS, Lu Y, et al. Novel findings of anti-cancer property of propofol. Anticancer Agents Med Chem. 2018;18(2):156–165. doi:10.2174/1871520617666170912120327
   PubMed Web of Science ®Google Scholar
• Freeman J, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine, propofol and steroids on pulmonary metastasis in a murine model of breast cancer surgery. Cancers (Basel). 2019;11(5):613. doi:10.3390/cancers11050613
   PubMed Web of Science ®Google Scholar
• Li R, Huang Y, Lin J. Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/STAT3 pathway in mouse models. Nat Commun. 2020;11(1):642. doi:10.1038/s41467-019-14065-6
   PubMed Web of Science ®Google Scholar
• Wang W, Lin C, Zhang Y, Chen Y, Guo P. [Effects of propofol on pulmonary metastasis of intravenously injected MADB106 tumor cells and expression of E-cadherin and β-catenin in rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(6):852–856. Chinese.
   PubMedGoogle Scholar
• Zhang Y, Lin C, Wang W, Chen Y. [Effects of propofol on pulmonary metastasis of intravenous injected tumor cells and expressions of MTA1 and Wnt1 in rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(7):1011–1015. Chinese.
   PubMedGoogle Scholar
• Ye HJ, Bai JJ, Guo PP, Wang W, Lin CS. [Propofol suppresses invasion of human lung cancer A549 cells by down-regulating aquaporin-3 and matrix metalloproteinase-9]. Nan Fang Yi Ke Da Xue Xue Bao. 2016;36(9):1286–1290. Chinese.
   PubMedGoogle Scholar
• Cui WY, Liu Y, Zhu YQ, Song T, Wang QS. Propofol induces endoplasmic reticulum (ER) stress and apoptosis in lung cancer cell H460. Tumour Biol. 2014;35(6):5213–5217. doi:10.1007/s13277-014-1677-7
   PubMedGoogle Scholar
• Wu KC, Yang ST, Hsia TC, et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 2012;32(11):4833–4842.
   PubMed Web of Science ®Google Scholar
• Yang N, Liang Y, Yang P, Ji F. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer. Oncol Rep. 2017;37(5):2611–2619. doi:10.3892/or.2017.5514
   PubMed Web of Science ®Google Scholar
• Liu WZ, Liu N. Propofol inhibits lung cancer A549 cell growth and epithelial-mesenchymal transition process by upregulation of microRNA-1284. Oncol Res. 2018;27(1):1–8. doi:10.3727/096504018X15172738893959
   PubMed Web of Science ®Google Scholar
• Sun H, Gao D. Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372. BMC Cancer. 2018;18(1):1252. doi:10.1186/s12885-018-5175-y
   PubMed Web of Science ®Google Scholar
• Xing SG, Zhang KJ, Qu JH, Ren YD, Luan Q. Propofol induces apoptosis of non-small cell lung cancer cells via ERK1/2-dependent upregulation of PUMA. Eur Rev Med Pharmacol Sci. 2018;22(13):4341–4349. doi:10.26355/eurrev_201807_15431
   PubMed Web of Science ®Google Scholar
• Jing XG, Chen TF, Huang C, et al. MiR-15a expression analysis in non-small cell lung cancer A549 cells under local hypoxia microenvironment. Eur Rev Med Pharmacol Sci. 2017;21(9):2069–2074.
   PubMed Web of Science ®Google Scholar
• Yang SL, Ren QG, Wen L, Hu JL. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2016;36(3):321–327. doi:10.1007/s11596-016-1586-7
   PubMedGoogle Scholar
• Ren W, Mi D, Yang K, et al. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. Swiss Med Wkly. 2013;143:w13855. doi:10.4414/smw.2013.13855
   PubMed Web of Science ®Google Scholar
• Yang N, Liang Y, Yang P, Yang T, Jiang L. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression. Braz J Med Biol Res. 2017;50(1):e5794. doi:10.1590/1414-431x20165794
   PubMed Web of Science ®Google Scholar
• Jun IJ, Jo JY, Kim JI, et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Sci Rep. 2017;7(1):14020. doi:10.1038/s41598-017-14147-9
   PubMed Web of Science ®Google Scholar
• Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia. 2010;65(5):478–482. doi:10.1111/j.1365-2044.2010.06304.x
   PubMed Web of Science ®Google Scholar
• Chu CN, Wu KC, Chung WS, et al. Etomidate suppresses invasion and migration of human A549 lung adenocarcinoma cells. Anticancer Res. 2019;39(1):215–223. doi:10.21873/anticanres.13100
   PubMed Web of Science ®Google Scholar
• Liu J, Dong W, Wang T, et al. Effects of etomidate and propofol on immune function in patients with lung adenocarcinoma. Am J Transl Res. 2016;8(12):5748–5755.
   PubMed Web of Science ®Google Scholar
• Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol. 2012;25(3):376–384. doi:10.1097/ACO.0b013e328352b4a8
   PubMed Web of Science ®Google Scholar
• Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival–unraveling mechanisms and revealing new indications. Pharmacol Rev. 2004;56(3):351–369. doi:10.1124/pr.56.3.2
   PubMed Web of Science ®Google Scholar
• Zylla D, Kuskowski MA, Gupta K, Gupta P. Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer. Br J Anaesth. 2014;113(Suppl 1):i109–i116. doi:10.1093/bja/aeu351
   PubMedGoogle Scholar
• Fujioka N, Nguyen J, Chen C, et al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg. 2011;113(6):1353–1364. doi:10.1213/ANE.0b013e318232b35a
   PubMed Web of Science ®Google Scholar
• Boehncke S, Hardt K, Schadendorf D, Henschler R, Boehncke WH, Duthey B. Endogenous μ-opioid peptides modulate immune response towards malignant melanoma. Exp Dermatol. 2011;20(1):24–28. doi:10.1111/j.1600-0625.2010.01158.x
   PubMed Web of Science ®Google Scholar
• Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg. 2011;112(3):558–567. doi:10.1213/ANE.0b013e31820568af
   PubMed Web of Science ®Google Scholar
• Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res. 2006;72(1–2):3–11. doi:10.1016/j.mvr.2006.04.004
   PubMed Web of Science ®Google Scholar
• Singleton PA, Moss J. Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010;6(8):1237–1242. doi:10.2217/fon.10.99
   PubMed Web of Science ®Google Scholar
• Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004;11(4):255–260. doi:10.1159/000078444
   PubMed Web of Science ®Google Scholar
• Forget P, Collet V, Lavand’homme P, De Kock M. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol. 2010;27(3):233–240. doi:10.1097/EJA.0b013e32832d540e
   PubMed Web of Science ®Google Scholar
• Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3(4):900–908. doi:10.1002/cam4.236
   PubMed Web of Science ®Google Scholar
• Zylla D, Gourley BL, Vang D, et al. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer. 2013;119(23):4103–4110. doi:10.1002/cncr.28345
   PubMed Web of Science ®Google Scholar
• Maher DP, Wong W, White PF, et al. Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis. Br J Anaesth. 2014;113(Suppl 1):i88–94. doi:10.1093/bja/aeu192
   PubMed Web of Science ®Google Scholar
• Wang K, Qu X, Wang Y, Shen H, Liu Q, Du J. Effect of mu agonists on long-term survival and recurrence in nonsmall cell lung cancer patients. Medicine. 2015;94(33):e1333. doi:10.1097/MD.0000000000001333
   PubMed Web of Science ®Google Scholar
• Oh TK, Jeon JH, Lee JM, et al. Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery. PLoS One. 2017;12(7):e0181672. doi:10.1371/journal.pone.0181672
   PubMed Web of Science ®Google Scholar
• Ohta N, Ohashi Y, Fujino Y. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response. Anesth Analg. 2009;109(3):793–800. doi:10.1213/ane.0b013e3181adc384
   PubMed Web of Science ®Google Scholar
• Connolly JG, Tan KS, Mastrogiacomo B, et al. Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinoma. Br J Anaesth. 2021;127(1):75–84. doi:10.1016/j.bja.2021.03.030
   PubMed Web of Science ®Google Scholar
• Song JY, Lee SW, Hong JP, Chang SE, Choe H, Choi J. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. Cancer Lett. 2009;283(2):135–142. doi:10.1016/j.canlet.2009.03.034
   PubMed Web of Science ®Google Scholar
• Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol. 2002;129(1–2):18–24. doi:10.1016/S0165-5728(02)00165-0
   PubMed Web of Science ®Google Scholar
• Xia M, Tong JH, Ji NN, Duan ML, Tan YH, Xu JG. Tramadol regulates proliferation, migration and invasion via PTEN/PI3K/AKT signaling in lung adenocarcinoma cells. Eur Rev Med Pharmacol Sci. 2016;20(12):2573–2580.
   PubMed Web of Science ®Google Scholar
• Ming X, Jianhua T, Yipeng G, et al. Effects of tramadol combined with cisplatin on invasion and migration of human lung adenocarcinoma cell line A549. J Clin Anesthesiol. 2015;31(4):391⁃394.
   Google Scholar
• Wang C, Datoo T, Zhao H, et al. Midazolam and dexmedetomidine affect neuroglioma and lung carcinoma cell biology in vitro and in vivo. Anesthesiology. 2018;129(5):1000–1014. doi:10.1097/ALN.0000000000002401
   PubMed Web of Science ®Google Scholar
• Makin JH, Bae E, Bae E, et al. Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma. Biochem Biophys Res Commun. 2017;484(2):269–277. doi:10.1016/j.bbrc.2017.01.093
   PubMed Web of Science ®Google Scholar
• Lavon H, Matzner P, Benbenishty A, et al. Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. Br J Anaesth. 2018;120(1):188–196. doi:10.1016/j.bja.2017.11.004
   PubMed Web of Science ®Google Scholar
• Su X, Fan Y, Yang L, et al. Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery. J Transl Med. 2018;16(1):347. doi:10.1186/s12967-018-1727-9
   PubMed Web of Science ®Google Scholar
• Cata JP, Singh V, Lee BM, et al. Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery. J Anaesthesiol Clin Pharmacol. 2017;33(3):317–323. doi:10.4103/joacp.JOACP_299_16
   PubMedGoogle Scholar
• IddrisuBabaYabasin (Abasson). Effects of Cis Atracurium and Vecuronium on Human Lung Cancer and Hepatocellular Carcinoma Cells in vitro. Dalian Medical University; 2015.
   Google Scholar
• Feng X, Tao Z, Xueqin Z, et al. The inhibitory effect of sevoflurane pretreatment on lung metastasis of Lewis lung cancer cells in mice. J Clin Anesthesiol. 2017;33(1):71–73.
   Google Scholar
• Johnson MZ, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018;121(1):76–85. doi:10.1016/j.bja.2017.12.043
   PubMed Web of Science ®Google Scholar
• Kim Y, Yun S, Shin KA, et al. Effects of sevoflurane on lewis lung carcinoma cell proliferation in vivo and in vitro. Medicina. 2021;57(1):45.
   PubMed Web of Science ®Google Scholar
• Hua L, Chengxiang Y, Heng L, Xianjie W, Qiaoling Z. [Effects of isoflurane and sevoflurane on apoptosis and expression of CD44 and CD54 in human lung cancer cell line A549]. Chin J Anesthesiol. 2010;30(04):389, 391. Chinese.
   Google Scholar
• Liang H, Gu M, Yang C, Wang H, Wen X, Zhou Q. Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway. J Anesth. 2012;26(3):381–392. doi:10.1007/s00540-011-1317-y
   PubMed Web of Science ®Google Scholar
• Liang H, Wang HB, Liu HZ, Wen XJ, Zhou QL, Yang CX. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549. Biomed Pharmacother. 2013;67(6):503–509. doi:10.1016/j.biopha.2013.03.005
   PubMed Web of Science ®Google Scholar
• Ciechanowicz S, Zhao H, Chen Q, et al. Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro. Br J Anaesth. 2018;120(2):368–375. doi:10.1016/j.bja.2017.11.066
   PubMed Web of Science ®Google Scholar
• Liang H, Gu MN, Yang CX, Wang HB, Wen XJ, Zhou QL. Sevoflurane inhibits proliferation, induces apoptosis, and blocks cell cycle progression of lung carcinoma cells. APJCP. 2011;12(12):3415–3420.
   Google Scholar
• Liang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α. J Anesth. 2015;29(6):821–830. doi:10.1007/s00540-015-2035-7
   PubMed Web of Science ®Google Scholar
• Wang L, Wang T, Gu JQ, Su HB. Volatile anesthetic sevoflurane suppresses lung cancer cells and miRNA interference in lung cancer cells. Onco Targets Ther. 2018;11:5689–5693. doi:10.2147/OTT.S171672
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao X. Isoflurane promotes non-small cell lung cancer malignancy by activating the Akt-mammalian target of rapamycin (mTOR) signaling pathway. Med Sci Monit. 2016;22:4644–4650. doi:10.12659/MSM.898434
   PubMed Web of Science ®Google Scholar
• Ren J, Wang X, Wei G, Meng Y. Exposure to desflurane anesthesia confers colorectal cancer cells metastatic capacity through deregulation of miR-34a/LOXL3. Eur J Cancer Prev. 2021;30(2):143–153. doi:10.1097/CEJ.0000000000000608
   PubMed Web of Science ®Google Scholar
• Shapiro J, Jersky J, Katzav S, Feldman M, Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest. 1981;68(3):678–685. doi:10.1172/JCI110303
   PubMed Web of Science ®Google Scholar
• Hosomi Y, Yokose T, Hirose Y, et al. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer. 2000;30(2):73–81. doi:10.1016/S0169-5002(00)00132-X
   PubMed Web of Science ®Google Scholar
• Yoshimatsu K, Altorki NK, Golijanin D, et al. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res. 2001;7(9):2669–2674.
   PubMed Web of Science ®Google Scholar
• Zappavigna S, Cossu AM, Grimaldi A, et al. Anti-inflammatory drugs as anticancer agents. Int J Mol Sci. 2020;21(7):2605. doi:10.3390/ijms21072605
   PubMed Web of Science ®Google Scholar
• Takiuchi T, Blake EA, Matsuo K, Sood AK, Brasky TM. Aspirin use and endometrial cancer risk and survival. Gynecol Oncol. 2018;148(1):222–232. doi:10.1016/j.ygyno.2017.10.026
   PubMed Web of Science ®Google Scholar
• Vogel U, Christensen J, Wallin H, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res. 2008;639(1–2):89–100. doi:10.1016/j.mrfmmm.2007.11.004
   PubMed Web of Science ®Google Scholar
• Hollmann MW, Durieux ME, Fisher D. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000;93(3):858–875. doi:10.1097/00000542-200009000-00038
   PubMed Web of Science ®Google Scholar
• Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 2019;47(1):2866–2874. doi:10.1080/21691401.2019.1636807
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis EG, Bakhshi FR, et al. Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation. Anesthesiology. 2014;120(6):1414–1428. doi:10.1097/ALN.0000000000000174
   PubMed Web of Science ®Google Scholar
• Grandhi RK, Perona B. Mechanisms of action by which local anesthetics reduce cancer recurrence: a systematic review. Pain Med. 2020;21(2):401–414. doi:10.1093/pm/pnz139
   PubMed Web of Science ®Google Scholar
• Piegeler T, Schlapfer M, Dull RO, et al. Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFalpha-induced vasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. Br J Anaesth. 2015;115(5):784–791. doi:10.1093/bja/aev341
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis EG, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117(3):548–559. doi:10.1097/ALN.0b013e3182661977
   PubMed Web of Science ®Google Scholar
• Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology. 2012;116(4):841–5687. doi:10.1097/ALN.0b013e31824babfe
   PubMed Web of Science ®Google Scholar
• Ma XW, Li Y, Han XC, Xin QZ. The effect of low dosage of procaine on lung cancer cell proliferation. Eur Rev Med Pharmacol Sci. 2016;20(22):4791–4795.
   PubMed Web of Science ®Google Scholar
• Freeman J, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine and cisplatin on metastasis in a murine model of breast cancer surgery. Anticancer Res. 2018;38(10):5599–5606. doi:10.21873/anticanres.12894
   PubMed Web of Science ®Google Scholar
• Vahabi S, Eatemadi A. Effects of anesthetic and analgesic techniques on cancer metastasis. Biomed Pharmacother. 2017;87:1–7. doi:10.1016/j.biopha.2016.12.073
   PubMed Web of Science ®Google Scholar
• Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000;10(2):165–169. doi:10.1097/00008390-200004000-00009
   PubMed Web of Science ®Google Scholar
• Xu YJ, Li SY, Cheng Q, et al. Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 2016;71(2):147–154.
   PubMed Web of Science ®Google Scholar
• Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis? Can J Anaesthes. 2016;63(2):184–192. doi:10.1007/s12630-015-0523-8
   PubMed Web of Science ®Google Scholar
• Wang W, Xiao J, Shen S, Wang S, Chen M, Hu Y. Emerging effect of anesthesia on post-operative tumor recurrence and metastasis. J Int Med Res. 2019;47(8):3550–3558. doi:10.1177/0300060519861455
   PubMed Web of Science ®Google Scholar
• Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124(1):69–79. doi:10.1097/ALN.0000000000000936
   PubMed Web of Science ®Google Scholar
• Hayasaka K, Shiono S, Miyata S, Takaoka S, Endoh M, Okada Y. Prognostic significance of propofol-based intravenous anesthesia in early-stage lung cancer surgery. Surg Today. 2021;51(8):1300–1308. doi:10.1007/s00595-020-02216-y
   PubMed Web of Science ®Google Scholar
• Wu WW, Zhang WH, Zhang WY, et al. The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study. BMC Cancer. 2021;21(1):1193. doi:10.1186/s12885-021-08946-7
   PubMed Web of Science ®Google Scholar
• Oh TK, Kim K, Jheon S, et al. Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery: a retrospective propensity matching analysis. Cancer Control. 2018;25(1):1073274818775360. doi:10.1177/1073274818775360
   Web of Science ®Google Scholar
• Soltanizadeh S, Degett TH, Gögenur I. Outcomes of cancer surgery after inhalational and intravenous anesthesia: a systematic review. J Clin Anesth. 2017;42:19–25.
   PubMed Web of Science ®Google Scholar
• Jang D, Lim CS, Shin YS, et al. A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis. BMC Anesthesiol. 2016;16:16. doi:10.1186/s12871-016-0181-6
   PubMed Web of Science ®Google Scholar
• Zheng W, Li YP, Lai RC, Lu YL, Shen ZW, Wang XD. [Effects of neuraxial block and general anesthesia on tumor metastasis in rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(12):2218–2220. Chinese.
   PubMedGoogle Scholar
• Lee EK, Ahn HJ, Zo JI, Kim K, Jung DM, Park JH. Paravertebral block does not reduce cancer recurrence, but is related to higher overall survival in lung cancer surgery: a retrospective cohort study. Anesth Analg. 2017;125(4):1322–1328. doi:10.1213/ANE.0000000000002342
   PubMed Web of Science ®Google Scholar
• Pi J, Sun Y, Zhang Z, Wan C. Combined anesthesia shows better curative effect and less perioperative neuroendocrine disorder than general anesthesia in early stage NSCLC patients. J Int Med Res. 2019;47(10):4743–4752. doi:10.1177/0300060519862102
   PubMed Web of Science ®Google Scholar
• Xu Q, Shi NJ, Zhang H, Zhu YM. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non‑small cell lung cancer: a comparative study. Mol Med Rep. 2017;16(4):4445–4454. doi:10.3892/mmr.2017.7144
   PubMed Web of Science ®Google Scholar
• Chen J, Luo F, Lei M, Chen Z. A study on cellular immune function of patients treated with radical resection of pulmonary carcinoma with two different methods of anesthesia and analgesia. J BUON. 2017;22(6):1416–1421.
   PubMed Web of Science ®Google Scholar
• Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials. 2008;29(4):517–526. doi:10.1016/j.cct.2008.01.002
   PubMed Web of Science ®Google Scholar
• Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev. 2008;17(3):269–272. doi:10.1097/CEJ.0b013e3282f0c005
   PubMed Web of Science ®Google Scholar
• Sen Y, Xiyang H, Yu H. Effect of thoracic paraspinal block-propofol intravenous general anesthesia on VEGF and TGF-β in patients receiving radical resection of lung cancer. Medicine. 2019;98(47):e18088. doi:10.1097/MD.0000000000018088
   PubMed Web of Science ®Google Scholar
• Wu HL, Tai YH, Chan MY, Tsou MY, Chen HH, Chang KY. Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study. BMJ Open. 2019;9(5):e027618. doi:10.1136/bmjopen-2018-027618
   PubMed Web of Science ®Google Scholar